Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 8, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc.
| 3.76K |
$13.85 | $52,103.70 | +3.64% | 107.15K |
Mar 6
| |||||||
Apellis Pharmaceuticals, Inc.
| -781.00 |
$67.77 | -$52,925.95 | -0.75% | 103.39K |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -906.00 |
$64.14 | -$58,109.21 | -0.86% | 104.17K |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -4.18K |
$65.00 | -$271,943.26 | -3.83% | 105.08K |
Jan 22
| |||||||
Apellis Pharmaceuticals, Inc.
| 19.51K |
$66.81 | -$283,268.46 | +21.74% | 109.26K |
Jan 16
| |||||||
Apellis Pharmaceuticals, Inc.
| 4K |
$35.54 | -$113,987.54 | +4.66% | 89.75K |
Dec 19
| |||||||
Apellis Pharmaceuticals, Inc.
| -8.51K |
$89.98 | -$765,729.80 | -9.03% | 85.75K |
Jul 3
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 174.97K |
Jun 28
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 174.97K |
Apr 21
| |||||||
Apellis Pharmaceuticals, Inc.
| 9.06K |
$58.50 | -$48,262.50 | +5.46% | 174.97K |
Feb 21
| |||||||
Apellis Pharmaceuticals, Inc.
| -532.00 |
$51.21 | -$27,243.72 | -0.32% | 165.91K |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| -551.00 |
$52.77 | -$29,076.27 | -0.33% | 166.44K |
Jan 27
| |||||||
Apellis Pharmaceuticals, Inc.
| -2.03K |
$52.05 | -$105,869.70 | -1.20% | 166.99K |
Jan 20
| |||||||
Apellis Pharmaceuticals, Inc.
| 53.45K |
—
|
—
| +46.25% | 169.02K |
Jan 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -10.00K |
$44.51 | -$445,140.00 | -7.96% | 115.57K |
Jun 22
| |||||||
Apellis Pharmaceuticals, Inc.
| -6.88K |
$50.00 | -$250,000.00 | -5.19% | 125.57K |
Apr 21 - Apr 25
| |||||||
Apellis Pharmaceuticals, Inc.
| -491.00 |
$47.12 | -$23,135.92 | -0.37% | 132.44K |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| -650.00 |
$38.59 | -$25,083.50 | -0.49% | 132.94K |
Jan 28
| |||||||
Apellis Pharmaceuticals, Inc.
| 26.05K |
—
|
—
| +24.23% | 133.59K |
Jan 21
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.20K |
$48.50 | -$58,200.00 | -1.10% | 107.53K |
Dec 27
| |||||||
Apellis Pharmaceuticals, Inc.
| 9.54K |
$31.11 | -$215,698.22 | +9.62% | 108.73K |
Dec 22
| |||||||
Apellis Pharmaceuticals, Inc.
| 954 |
$4.31 | $4,111.74 | +0.97% | 99.19K |
Sep 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 489 |
$4.31 | $2,107.59 | +0.50% | 98.24K |
Jun 21
| |||||||
Apellis Pharmaceuticals, Inc.
| 489 |
$4.31 | $2,107.59 | +0.50% | 97.75K |
May 28
| |||||||
Apellis Pharmaceuticals, Inc.
| 489 |
$4.31 | $2,107.59 | +0.51% | 97.26K |
Apr 22
| |||||||
Apellis Pharmaceuticals, Inc.
| 978 |
$4.31 | $4,215.18 | +1.02% | 96.77K |
Mar 22
| |||||||
Apellis Pharmaceuticals, Inc.
| -468.00 |
$47.72 | -$22,332.96 | -0.49% | 95.79K |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 9.38K |
—
|
—
| +10.79% | 96.26K |
Jan 28
| |||||||
Apellis Pharmaceuticals, Inc.
| 43.48K |
$4.01 | $174,519.18 | +100.18% | 86.89K |
Jan 27
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$32.39 | -$680,035.43 |
—
| 43.4K |
Dec 11 - Dec 14
| |||||||
Apellis Pharmaceuticals, Inc.
| 8.88K |
$23.59 | -$202,461.65 | +26.09% | 42.92K |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 12K |
$21.57 | -$81,351.00 | +54.44% | 34.04K |
Jan 27
| |||||||
Apellis Pharmaceuticals, Inc.
| 5K |
$2.67 | $13,350.00 | +29.34% | 22.04K |
Aug 7
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 17.04K |
$10.73 | -$208,712.32 |
∞
| 17.04K |
Sep 14
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$2.67 | $1,666.08 |
—
|
0
|
May 29
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 16
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.